Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients

NCT03117348 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 411

Last updated 2020-09-22

No results posted yet for this study

Summary

Patients will be randomized to Gradual or immediate Goal-dose EN group at day 3 after abdominal surgery. Patients will receive Goal-dose EN gradually or immediately after abdominal surgery. Both groups will receive EN for 5 days except 80% of target energy delivered by oral feeding or patients are discharged from hospital. The primary and secondary outcomes will be collected.

Conditions

  • Enteral Nutrition
  • Postoperative Period
  • Digestive System Neoplasms

Interventions

OTHER

Enteral nutrition

Patients in Gradual Goal-dose EN group will receive increased calories gradually by EN and will reach the 80% of target energy by EN at day 8 while patients in immediate Goal-dose EN group will receive 100% of target energy by EN at day 3 after abdominal surgery. Both of the two group will receive EN for 5 days except 80% of target energy delivered by oral feeding or patients are discharged from hospital, whichever arrives first.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER
  • Chinese PLA General Hospital

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Xijing Hospital

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Xinqiao Hospital of Chongqing

    collaborator OTHER
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER
  • Changhai Hospital

    collaborator OTHER
  • Shanghai 10th People's Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • First Affiliated Hospital of Kunming Medical University

    collaborator OTHER
  • Jinling Hospital, China

    lead OTHER

Principal Investigators

  • Xinying Wang, MD · Jinling Hospital, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-15
Primary Completion
2018-12-24
Completion
2019-02-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03117348 on ClinicalTrials.gov